Filing search / Precipio Inc / "Customer"

10-K

2001 FY

EX-10.11

PRPO Precipio Inc

25 Mar 02

Annual report

12:00am

, including all exhibits hereto, as the same may be amended or otherwise modified from time to time. "CUSTOMER" shall mean a party with whom either TBIO … ) received from a Customer to which each party of this Agreement shall be entitled. The percentage amount of the Revenue Split to each party is further

8-K

EX-99.1

PRPO Precipio Inc

25 Feb 22

Precipio Releases Year-End 2021 Preliminary Unaudited Results and Outlook for 2022

6:51pm

customers, but also an increase in revenue per customer due to expanded utilization of multiple panels. In anticipation of both increases in market … acceptance and new customer contracts, we recently completed building out our product production and technical support capabilities. For 2022, we anticipate

10-Q

2002 Q3

PRPO Precipio Inc

12 Nov 02

Quarterly report

12:00am

arrangement. Such recognition is based on receipt of an unconditional customer order and transfer of title and risk of ownership to the customer, typically … recognized $1.5 million in revenue in a transaction with a customer whereby the product sold, fulfilling the customers purchase order, was shipped

10-Q

2022 Q1

PRPO Precipio Inc

11 May 22

Quarterly report

4:01pm

. For certain customers in the HSRR program, the Company leases diagnostic testing equipment and then subleases the equipment to the customer. Finance lease ROU … equipment from the Company with the transfer of ownership to the customer at the end of the lease term at no additional cost. For these contracts

10-Q

2021 Q2

PRPO Precipio Inc

12 Aug 21

Quarterly report

4:07pm

our HSRR program, the customer can generate in-house testing revenues through reagent purchase contracts and economical lease-to-own rates instead … of sending out the same tests to large commercial reference laboratories. The HSRR customer also benefits from obtaining faster results, thus ultimately

10-Q

sbxrkh

14 May 21

Quarterly report

4:01pm

10-Q

mrxhzv566hq uijwa8

11 Aug 22

Quarterly report

4:02pm

10-Q

0dy 70lfhp

12 Nov 21

Quarterly report

4:02pm

10-K

jb2 6qluxmbnp5o0

31 Mar 06

Annual report

12:00am

10-Q

sfwvg2kw3mz99m

14 Aug 02

Quarterly report

12:00am

8-K

EX-99.1

cgczfed

28 Jul 21

Precipio Announces Preliminary Unaudited Q2-2021 Revenues of $2.3M

4:41pm

10-Q

eg9n9gli 3sb

13 Nov 19

Quarterly report

4:33pm

10-K

hkm22phw u70xduwiz

2 Apr 07

Annual report

12:00am

8-K

EX-99.1

1m6daby9

26 Sep 19

Clinical Validations for IV-Cell™ and HemeScreen™ Completed

4:43pm

10-Q

johh9m6 kjy7lo

10 Nov 22

Quarterly report

4:02pm

10-Q

ic1 3pfvt15jd

9 Aug 19

Quarterly report

2:55pm

10-Q

jtoqu

14 May 02

Quarterly report

12:00am

10-Q

eemzz9o3jx iimz

21 May 18

Quarterly report

3:16pm

8-K

EX-99.1

wv6msw

30 Nov 10

Entry into a Material Definitive Agreement

12:00am

10-K

dplfjl1pdfuez2qsev

27 Mar 20

Annual report

3:47pm